More than 50% of the women in the phase III trial were diagnosed as stage IV patients (metastasized disease. ) of those 725 women , 700 were disease free within the first three months of treatment.
RuiNA was taken daily in pill form by the women in the trial. The 200 mg pill costs $2150 for a month of treatment and will be covered by insurance. RuiNA will be produced by Bristol- Merck beginning next year. This is a major step in the treatment of Ovarian Cancer. Work still remains in finding a screening test.
Still part of me wishes this was true.
Every Day is a Blessing!